Panbela Therapeutics, Inc. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Panbela Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Panbela Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 546 %, a 38.9% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2023 was -72.7K %, a 7687% decline from 2022.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2022 was 958 %.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2021 was -109 %, a 16.3% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -72.7K -73.7K -7687% Jan 1, 2023 Dec 31, 2023
2022 958 +1.07K Jan 1, 2022 Dec 31, 2022
2021 -109 -15.3 -16.3% Jan 1, 2021 Dec 31, 2021
2020 -93.9 +714 +88.4% Jan 1, 2020 Dec 31, 2020
2019 -808 -1.76K -185% Jan 1, 2019 Dec 31, 2019
2018 951 +303 +46.8% Jan 1, 2018 Dec 31, 2018
2017 648 +505 +353% Jan 1, 2017 Dec 31, 2017
2016 143 -227 -61.3% Jan 1, 2016 Dec 31, 2016
2015 370 -266 -41.9% Jan 1, 2015 Dec 31, 2015
2014 636 +712 Jan 1, 2014 Dec 31, 2014
2013 -76.5 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.